Reduced CD5+CD24hiCD38hi and interleukin‐10+ regulatory B cells in active anti‐neutrophil cytoplasmic autoantibody‐associated vasculitis permit increased circulating autoantibodies

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2249|180|2|178-188

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.180, Iss.2, 2015-05, pp. : 178-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peripheral CD5+ B Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 2, 2015-02 ,pp. : 535-544

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of Tumor Necrosis Factor Receptors on Granulocytes in Patients with Myeloperoxidase Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis

By  

Nephron Clin Pract, Vol. 113, Iss. 3, 2009-08 ,pp. : c222-c233

Karger

Access to resources Recommend Favorite

Serum Levels of BAFF and APRIL in Myeloperoxidase Anti-Neutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis: Association with Disease Activity

By  

Nephron Clin Pract, Vol. 118, Iss. 4, 2011-02 ,pp. : c339-c345

Karger

Access to resources Recommend Favorite

CD14 expression is increased on monocytes in patients with anti‐neutrophil cytoplasm antibody (ANCA)‐associated vasculitis and correlates with the expression of ANCA autoantigens

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 1, 2015-07 ,pp. : 65-75

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathogenesis of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis and Potential Targets for Biologic Treatment

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 216-223

Karger

Access to resources Recommend Favorite